JPMorgan's year-to-date gains, NII growth outlook and investment banking pipeline headline today's standout Zacks research ...

ABBV rebounds after its Q3 dip as strong immunology and neuroscience growth offset Humira erosion and aesthetics weakness.

For the third straight quarter, AbbVie has jacked up its revenue forecast for 2025. The Illinois drugmaker has raised its guidance by $400 million, now expecting sales to reach $60.9 billion. The ...

Pfizer seals the deal with Metsera for $10 billion after Novo Nordisk bowed out; President Donald Trump welcomes executives from Novo and Eli Lilly to the White House to announce that the companies’ ...

The worry with Abbvie was that once the Humira patent expired, this would be a business in huge decline. Well, the patent expired and two new drugs took the torch. During their latest earnings call, ...

This lighthearted moment shows how music becomes the bridge to grab someone’s attention in a fun and respectful way. #ViolinMoment #MusicAndConnection #GettingAttention #LightheartedMusic #ViolinCharm ...

Market opportunities in the IBD treatment sector include the rising demand for targeted therapies and biologics due to a deeper understanding of the disease, alongside the expansion of biosimilar ...

AbbVie raised its full-year adjusted earnings outlook, even though profit was pressured by increased expenses during the third quarter. The North Chicago, Ill., drugmaker on Friday said it now expects ...

Despite the pharmaceutical giant's beat-and-raise third quarter, investors were expecting better. Profitability guidance, even though it was raised, came in under analyst estimates. For its third ...

Jackson, Mississippi, will host the 82nd National Folk Festival for a three-year residency from 2025 to 2027. The festival will feature over 300 musicians, dancers, and craftspeople with performances ...